XML 36 R16.htm IDEA: XBRL DOCUMENT
v3.20.2

Investments | 9 Months Ended
--- | ---
Sep. 26, 2020
Investments [Abstract] |
Investments | INVESTMENTS The following table summarizes the measurement category, balance sheet location, and balances of our equity securities (in millions):
Measurement Category |  | Balance Sheet Location |  | September 26, 2020 |  | December 31, 2019
Fair value method |  | Prepaid expenses and other current assets |  | $ | 3.3 |  |  | $ | 6.6 |
Fair value method(1) |  | Other non-current assets |  | $ | 1.8 |  |  | $ | 2.3 |
Equity method |  | Other non-current assets |  | $ | 69.5 |  |  | $ | 17.8 |
(1) | Measured at fair value using the Net Asset Value practical expedient.
The following table summarizes the expense (income) recognized in earnings of our equity securities (in millions):
|  |  |  | Three Months Ended | Nine Months Ended
Measurement Category |  | Income Statement Location |  | September 26, 2020 |  | September 28, 2019 | September 26, 2020 |  | September 28, 2019
Fair value method |  | Other (income) expense, net |  | $ | (0.4 | ) |  | $ | 0.9 |  | $ | 2.2 |  |  | $ | 8.8 |
Equity method |  | Other (income) expense, net |  | $ | (1.1 | ) |  | $ | (0.3 | ) | $ | (2.6 | ) |  | $ | (2.1 | )
On June 17, 2020, we announced our entrance into the cannabidiol (“CBD”) market through a strategic investment in and long-term supply agreement with Kazmira LLC ("Kazmira"), a leading supplier of hemp-based CBD products free of tetrahydrocannabinol (“THC-free”) based in Watkins, Colorado. In addition to the supply agreement, we acquired an approximate 20% equity stake in Kazmira for $50.0 million with $15.0 million paid at close of the transaction and the balance due within 18 months thereafter. Our minority equity investment initiates the first phase of the partnership in which we will collaborate to scale-up Kazmira’s facilities and laboratories, in accordance with current Good Manufacturing Practices, to produce THC-free CBD from industrial hemp that meets our standards for reliability and consistency. In the second phase of the partnership, we will work to launch THC-free hemp-based CBD products in a number of global markets, while leveraging our supply agreement with Kazmira, which is exclusive for the U.S. store brand market. We will report our equity method earnings from Kazmira in our Condensed Consolidated Financial Statements on a quarterly lag.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration